Board Committees

Ezra Friedberg has served as a member of our board of directors since May 2021. Since September 2011, Mr. Friedberg has served as co-founder and general partner of Multiplier Capital, a fund focused on lending opportunities to sponsor-backed growth companies. He is also a member of the fund’s credit committee. Mr. Friedberg is a seasoned investor with more than twenty years of investing experience in both public and private companies. He invests actively in the biotech space and has served on the board of directors of Humanigen (Nasdaq: HGEN), a clinical-stage biopharmaceutical company which develops monoclonal antibodies. His other investments include private equity, venture capital, and property across the United States, Canada and overseas. Separately, Mr. Friedberg manages and owns other investments and businesses through Liberty Peak Capital, Key Recovery Group, and related companies. Mr. Friedberg is a graduate of Johns Hopkins University. He has founded and is an active board member of several community and civic organizations, including a non-profit mentoring agency. Mr. Friedberg serves and has served on several for-profit and non-profit boards. He was selected to serve on our board of directors due to his investment experience and his knowledge of our industry.

Chia-Lin Simmons is the CEO of LogicMark, Inc. (Nasdaq: LGMK). The company provides health communications devices and technologies to create a Connected Care Platform. Prior to joining LogicMark, Ms. Simmons was the CEO/Co-Founder of LookyLoo, a patent-pending AI social commerce company. She was the former Head of Global Partner Marketing for Google's Google Play Music and Google Play Store; former VP of Marketing & Content for Harman International / Samsung’s Connected Car business; a Senior Business Development executive at Time Warner / AOL, and the former VP of Strategic Alliances at Audible / Amazon.

Ms. Simmons served on the Board of Directors (2017 – 2022) for Servco Pacific, a multi-billion dollar global company where she sat on the Audit Committee. She currently serves on the Investment Board. She is a current Board Member of New Energy Nexus, an international NGO that support clean energy entrepreneurs with funds and accelerators serves on its Nominating Committee. Ms. Simmons graduated Magna cum Laude and Phi Beta Kappa from U.C. San Diego. She received her MBA from Cornell University, where she was a Park Leadership Fellow and her JD from George Mason University School of Law. She is a licensed New York State attorney.

Dr. Richard Malamut has served as a member of our board of directors since January 2023. Dr. Malamut is currently Chief Medical Officer at MedinCell Inc. He was most recently Chief Medical Officer and Executive Vice President at Collegium Pharmaceuticals from April 2019 to May 2022 and has also served as Chief Medical Officer for Braeburn Pharmaceuticals, Inc. from 2018 to 2019 where he was responsible for the company’s medical affairs, non-clinical and clinical development, clinical operations, research and development quality assurance, and pharmacovigilance functions. Prior to that, Dr. Malamut had similar responsibilities as Chief Medical Officer at Avanir Pharmaceuticals from 2016 to 2018 and was Senior Vice President of Global Clinical Development at Teva Pharmaceutical Industries Ltd from 2013 to 2016 where he was responsible for Pain, Neuropsychiatry, Oncology, and New Therapeutic Entities. His experience also includes roles of increasing responsibility focusing on early clinical development and translational medicine in Neurology, Psychiatry and Analgesia at Bristol-Myers Squibb and AstraZeneca. Dr. Malamut earned his medical degree from Hahnemann University in Philadelphia and completed both a residency in Neurology and a fellowship in Neuromuscular disease. He worked as a board-certified academic and clinical neurologist for 17 years and has more than 50 publications in the fields of pain medicine, neuromuscular disease, autonomic disease, and neurodegenerative disease.

Chia-Lin Simmons is the CEO of LogicMark, Inc. (Nasdaq: LGMK). The company provides health communications devices and technologies to create a Connected Care Platform. Prior to joining LogicMark, Ms. Simmons was the CEO/Co-Founder of LookyLoo, a patent-pending AI social commerce company. She was the former Head of Global Partner Marketing for Google's Google Play Music and Google Play Store; former VP of Marketing & Content for Harman International / Samsung’s Connected Car business; a Senior Business Development executive at Time Warner / AOL, and the former VP of Strategic Alliances at Audible / Amazon.

Ms. Simmons served on the Board of Directors (2017 – 2022) for Servco Pacific, a multi-billion dollar global company where she sat on the Audit Committee. She currently serves on the Investment Board. She is a current Board Member of New Energy Nexus, an international NGO that support clean energy entrepreneurs with funds and accelerators serves on its Nominating Committee. Ms. Simmons graduated Magna cum Laude and Phi Beta Kappa from U.C. San Diego. She received her MBA from Cornell University, where she was a Park Leadership Fellow and her JD from George Mason University School of Law. She is a licensed New York State attorney.

Chia-Lin Simmons is the CEO of LogicMark, Inc. (Nasdaq: LGMK). The company provides health communications devices and technologies to create a Connected Care Platform. Prior to joining LogicMark, Ms. Simmons was the CEO/Co-Founder of LookyLoo, a patent-pending AI social commerce company. She was the former Head of Global Partner Marketing for Google's Google Play Music and Google Play Store; former VP of Marketing & Content for Harman International / Samsung’s Connected Car business; a Senior Business Development executive at Time Warner / AOL, and the former VP of Strategic Alliances at Audible / Amazon.

Ms. Simmons served on the Board of Directors (2017 – 2022) for Servco Pacific, a multi-billion dollar global company where she sat on the Audit Committee. She currently serves on the Investment Board. She is a current Board Member of New Energy Nexus, an international NGO that support clean energy entrepreneurs with funds and accelerators serves on its Nominating Committee. Ms. Simmons graduated Magna cum Laude and Phi Beta Kappa from U.C. San Diego. She received her MBA from Cornell University, where she was a Park Leadership Fellow and her JD from George Mason University School of Law. She is a licensed New York State attorney.

Dr. Richard Malamut has served as a member of our board of directors since January 2023. Dr. Malamut is currently Chief Medical Officer at MedinCell Inc. He was most recently Chief Medical Officer and Executive Vice President at Collegium Pharmaceuticals from April 2019 to May 2022 and has also served as Chief Medical Officer for Braeburn Pharmaceuticals, Inc. from 2018 to 2019 where he was responsible for the company’s medical affairs, non-clinical and clinical development, clinical operations, research and development quality assurance, and pharmacovigilance functions. Prior to that, Dr. Malamut had similar responsibilities as Chief Medical Officer at Avanir Pharmaceuticals from 2016 to 2018 and was Senior Vice President of Global Clinical Development at Teva Pharmaceutical Industries Ltd from 2013 to 2016 where he was responsible for Pain, Neuropsychiatry, Oncology, and New Therapeutic Entities. His experience also includes roles of increasing responsibility focusing on early clinical development and translational medicine in Neurology, Psychiatry and Analgesia at Bristol-Myers Squibb and AstraZeneca. Dr. Malamut earned his medical degree from Hahnemann University in Philadelphia and completed both a residency in Neurology and a fellowship in Neuromuscular disease. He worked as a board-certified academic and clinical neurologist for 17 years and has more than 50 publications in the fields of pain medicine, neuromuscular disease, autonomic disease, and neurodegenerative disease.